Latest news
Tiziana Life Sciences Stock (TLSA) Opinions on Clinical Trial Updates - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 17:37:00 GMTTiziana Life Sciences Reports Reduced Neuroinflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab - Quiver QuantitativeQuiver Quantitative · Fri, 31 Jul 2026 11:14:00 GMTReduced brain inflammation seen in MSA trial at Tiziana (Nasdaq: TLSA) - Stock TitanStock Titan · Fri, 31 Jul 2026 11:00:33 GMTTiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab - lincolnjournal.comlincolnjournal.com · Fri, 31 Jul 2026 11:00:00 GMTTiziana reports up to 34% drop in brain inflammation in third MSA patient on intranasal foralumab in Phase 2 trial - BitgetBitget · Fri, 31 Jul 2026 03:04:50 GMT